A new collaboration agreement between AstraZeneca, Oslo Cancer Cluster, and Oslo Science City aims to strengthen the Nordic health industry.
World-leading translational cancer research entered Oslo Cancer Cluster Innovation Park last week and created a buzz.
Meet the sponsors behind Cancer Crosslinks 2024: Bristol Myers Squibb and Daiichi-Sankyo.
Meet the members who recently joined or re-joined our cluster.
We regularly publish new videos to our YouTube channel. Please subscribe to stay up-to-date via the link below.